Clopidogrel, genotyping, coronary stenting, and guidelines
Links shared publicly online about this topic.
- 1,037total visits
Clopidogrel, genotyping, coronary stenting, and guidelines
When we know that simple testing can tell us a lot about patient risk and there is a substantial data set to support testing, why do policy makers continue to ignore the importance of individualized medicine?
View full resource at blogs.theheart.org
Tags: Coronary Stenting, Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on July 8, 2010 at 6:39 pm By:
Clopidogrel, genotyping, coronary stenting, and guidelines with Dr Eric Topol. Calling for individualized medicine. http://bit.ly/aVZy3z
Emergency Medicine Article | Acute Coronary Syndrome
mdlinx.com — “Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders Undergoing Coronary Stenting for Non ST Elevation Acute Coronary Syndrome” View full resource at mdlinx.com
Most Recently Shared on September 2, 2011 at 12:15 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Usefulness of High Clopidogrel Maintenance Dose According to CYP2C19 Genotypes in Clopidogrel Low Responders... http://t.co/IONGFyB #ER
Advertisement
